Named clinicians
No named clinician or professional credential is presented here without an independently verifiable affiliation. Organizational biographies and marketing descriptions are not treated as proof on their own.
Institutional profile · public-record review
Research Profile
Ibogaine Institute Of Mexico: Research Digest. This profile separates identifiable public evidence from organizational claims that could not be independently confirmed.
Scope and status
What this review can and cannot establish
This page reviews the named Ibogaine Institute of Mexico as an organization, not ibogaine as a general subject. It is intended to support a more careful reading of the wider ibogaine evidence and safety resource by keeping provider-specific claims distinct from the broader literature.
Public-facing naming alone does not establish corporate status, medical authorization, clinician employment, or research activity. No independently verifiable company registry entry, facility licensing document, named clinician affiliation, trial registration, or peer-reviewed publication was identified in the materials reviewed that could be reliably attributed to the named institute.
That finding should be read narrowly: a record not located in this review is not proof that it does not exist. It means the available evidence was insufficient to present those matters as verified facts. A separate account of the site’s standards for independent assessment explains why the distinction matters.
Public records
Registry and licensing questions remain separate
Mexico’s federal health regulator, COFEPRIS, is the appropriate federal point of reference for many health-regulatory questions. A public-facing organization name is not itself a licensing record, and a treatment-related site does not establish what authorization, if any, applies to a particular facility or service.
For this profile, no primary public document was located that clearly connected the named organization to a corporate registration or a clinic authorization. People evaluating claims about care in Mexico may find it useful to compare those claims with the practical questions raised in Mexican ibogaine treatment discussions, while still seeking current documentation directly from the relevant authority.
“Unconfirmed” is not an accusation. It is a record of what independent sources did not establish in this review.
Attribution check
Names, affiliations, trials, and publications
Reliable attribution requires a traceable match between a person, an institution, and a primary record. This profile does not name clinicians because no independently verifiable source was located that established employment or formal affiliation with the named institute. That restraint is especially important when considering materials about Baja ibogaine treatment settings, where a geographic description alone does not establish an organization’s clinical record.
Registered studies
A search of ClinicalTrials.gov is a useful check for registered clinical studies, but a result about ibogaine generally should not be attributed to this institute without a clear sponsor, site, or collaborator match.
Published research
Peer-reviewed work can inform questions about ibogaine, yet a paper’s subject matter does not establish involvement by a particular treatment organization unless its author affiliations, acknowledgements, or methods say so directly.
Context without inference
The wider research record is not provider-specific proof
Ibogaine is an indole alkaloid associated with plants in the Apocynaceae family; its general background is summarized by the ibogaine reference overview. That background does not confirm the practices, staffing, standards, or outcomes of a named organization.
Claims relating to opioid use also require particular care. Discussion of ibogaine and opioid addiction should not be read as evidence of established safety, suitability, or effectiveness for any individual. The FDA warning on serious risks associated with ibogaine use underscores why provider claims must never replace individualized medical evaluation and emergency planning.
Facility directories can be useful starting points for questions, but they are not validation systems. Information presented through ibogaine treatment facility listings should be checked against current primary documentation, including licensing and clinician information where it is applicable and available.
Common questions
How to use an incomplete public record
Uncertainty is information. It indicates where a claim needs documentation rather than confidence.
Does this profile verify that the institute is licensed?
No. This profile does not identify a primary public licensing record tying the named organization to a licensed treatment facility. The absence of a record located through this review is not proof that none exists.
Does an ibogaine claim establish medical effectiveness?
No. A treatment claim, testimonial, or organizational description is not equivalent to independently replicated clinical evidence, and it does not resolve safety questions for an individual. The same caution applies to narratives such as ibogaine documentary material, which may offer perspective without functioning as provider-specific verification.
Why distinguish an organization from the wider evidence base?
Research may concern ibogaine generally without involving a particular organization. Identifying that distinction helps prevent broad scientific interest from being presented as proof of a provider-specific record. Even adjacent discussions, including ibogaine and martial arts, require their own evidence and should not be used to infer an institutional relationship.
Practical conclusion
Request primary documents before relying on institutional claims.
The available public record reviewed here does not support confident claims about the Ibogaine Institute of Mexico’s corporate status, licensing, named clinical team, trials, or publications. For a structured way to weigh evidence, risk, and unanswered questions, consult the site’s safety and risk considerations.
Explore the research landscape